Human alpha-satellite HOXA9 promoter GAPDH promoter Anti-EZH2 Anti-193 804 853 P < 0.014 d Supplementary Figure 1. Data related to ChRIP. a. RT-qPCR analysis showing expression of the C-MYC in actinomycin D-(ActD-) treated or untreated BT-549 cells. C-MYC expression in treated and untreated cells was normalized to GAPDH expression. b. ChIP-qPCR result showing enrichment of EZH2 and H3K27me3 chromatin marks, represented as percentage of input, over the human alpha satellite repeats and the HOXA9 promoter, used as positive controls, in BT549 cells 1,2 . The GAPDH promoter was used as a negative control, and showed no enrichment in EZH2 and H3K27me3 ChIP. DNase I treatment resulted in loss of enrichment over the human alpha satellite repeats and HOXA9 promoter.
Supplementary Figure 4 . Data related to RNA-seq and RT-qPCR validation.
a. Figure showing the overlap of the deregulated protein-coding genes identified by microarray and RNA sequencing after downregulation of MEG3 and EZH2 using siRNA in BT-549 cells. The P values were obtained by performing a hypergeometric test using all protein-coding genes as a background.
b. Pathway analysis of the overlapped genes from microarray and RNA-seq after MEG3 and EZH2 downregulation in BT-549 cells, using KEGG annotation.
c. RT-qPCR analysis of TGFB2, TGFBR1, and SMAD2 gene expression in Ctrlsi-, MEG3si-, and EZH2si-transfected HF cells (± SD, n = 3).
d. RT-qPCR analysis of TGFB2, TGFBR1, and SMAD2 gene expression after overexpression of EZH2 in BT-549 cells, compared to control cells, 48 hours after transfection.
Supplementary Figure 5 . MEG3 regulates TGF-β pathway genes.
a. RT-qPCR analysis of ACTC1, CNN1, and COL5A1 gene expression in Ctrlsi-, MEG3si-, and EZH2si-transfected BT-549 cells (± SD, n = 3).
b. RT-qPCR analysis of ACTC1, CNN1, and COL5A1 gene expression in BT-549 cells after incubation with TGF-β2 ligand.
c. RT-qPCR analysis of ACTC1, CNN1, and COL5A1 gene expression in BT-549 cells transfected with Ctrlsi and Ctrlsi transfection followed by incubation with TGF-β2 ligand (Ctrlsi+ TGF-β ligand). Expression was also measured in MEG3si and MEG3si transfection followed by incubation with TGF-β inhibitor (MEG3sh+TGF-βin). The bar graph shows relative quantification of expression (± SD, n = 3) compared to the Ctrlsi transfection. Supplementary Figure 6 . MEG3 gene structure, association of the MEG3 peaks to the deregulated genes from microarray, RNA-seq and the overlapped deregulated genes from microarray and RNA-seq. c. b. The TGF-β pathway has a significant number of genes among the networks. Asterisks in red denote statistical significance. Ctrlsh MEG3sh EZH2 c. Enhancer activity of the TGFBR1-associated MEG3 peak. The bar graph represents the relative normalized firefly luciferase activity of the DNA element (around 1,200 bp) containing MEG3 peak associated with the TGFBR1 in Ctrlsh and MEG3sh transduced cells. Firefly luciferase activity was normalized with Renilla luciferase and is presented as luciferase activity in MEG3sh cells relative to Ctrlsh cells (± SD, n = 3). The P value was calculated using Student's t-test. The schematic diagram above the graph shows the location and distance of the MEG3 peak from the TGFBR1 gene promoter. The small gray bar below the MEG3 peak indicates the cloned DNA fragment. b. Left panel: CD spectra of a 1:1 mixture of TGFBR1 dsDNA and MEG3 TFO (ssRNA), shown in black, and a 1:1 mixture of TGFBR1 dsDNA and control ssRNA, shown in red. Inset: The difference between the two spectra. Right panel: The sum of the individual CD spectra for TGFBR1 dsDNA and MEG3 TFO (ssRNA), shown in black, and the sum of the individual CD spectra for TGFBR1 dsDNA and control ssRNA, shown in red. Inset: the difference between the two spectra. Technologies) . For ChRIP validation, we followed the same protocol as described above with or without ActD treatment using antibodies against H3K27me3, EZH2, H3K4me2 (Merck-Millipore) and non-specific Rabbit IgG (Merck-Millipore).
RNA Sequencing and alignment of H3K27me3, EZH2 and nuclear RNA samples
Using standard Applied Biosystems bioinformatics pipeline adapter sequences were removed from EZH2, H3K27me3 and nuclear RNA (Input) raw sequencing reads. We then aligned clean raw sequencing reads (25-75 nucleotides long) to the reference hg19 genome using 
Transcript abundance, differential expression analysis, finding T to C conversion and peak calling
The predicted known and non-annotated transcripts ( ChRIP (hypergeometric P value was used to calculate significance of the overlap, 6,205 lncRNAs were used as background) 11 . To visualize the differences in distribution of the reads in EZH2, H3K27me3 and input samples we have used MACS peak caller 12 Coding Potential Assessment Tool (CPAT) 14 .
We have used Freebayes 0.6.3 (Bayesian genetic variant detector) 15 to identify conversion sites in our ChRIP RNA-seq samples and looked for T to C (Thymine to Cytosine) transitions.
We obtained significantly higher number of T to C changes compared to other transitions. The transitions (T to C) were considered only if the minimum read depth >= 2 (total number of reads covered per transition position) 16 . The filtered T to C transitions were mapped to the known lncRNAs and non-annotated transcripts identified by Cufflinks.
Expression analysis by microarray and RNA sequencing after siRNA transfection
Total RNA was extracted 48 hours post siRNA transfection. Microarray hybridization was performed using Human Genome U133A 2.0 Array and the data was processed by following standard protocols from Uppsala Affymetrix Array Platform. The probe sets from EZH2si and 
RNA Immuno-precipitation (RIP), PRC2-MEG3 binding assay and Biotin-RNA pulldown assay
RIP assay was carried out using protocol from Guttman et al. 19 Trizol (life technologies). As a negative control, a reaction without PRC2 protein was used which helps to detect background non-specific binding of RNA to the antibody and beads.
Trizol extracted RNA was used in RT-qPCR to detect the enrichment of the bound MEG3
RNA over the negative control.
Biotin-RNA pull-down assay was carried out as in Tsai et al. 20 with the modifications as followed. Biotin-labeled WT sense, antisense and Δ345-348 MEG3 RNAs were synthesized using biotin RNA labeling mix (Roche) and incubated the in vitro synthesized RNAs with nuclear lysate from BT-549 cells followed by capturing with streptavidin-magnetic beads.
Bound proteins were eluted in SDS buffer and detected by Western blot with anti-EZH2 antibody (Cell Signalling).
RNA In situ hybridization
Fluorescence labeled probe to detect MEG3 was generated with a full length MEG3 cDNA using the BioPrime Array CGH Genomic Labeling system (Invitrogen). BT-549 cells were grown in Culturewell™ MultiWell cell culture system (Molecular Probes) for 36 hours followed by fixation, probe hybridization, washing, image capturing and image processing were performed as in Reinius et al. 21 .
Chromatin oligo affinity precipitation (ChOP)
Biotin labeled antisense DNA probes against full length MEG3 were designed using online 
Motif analysis and assignment of MEG3 peaks to genes using GREAT tool
Sequences within ±200 bp around MEG3 peak summits were extracted and motif analysis of these peaks was performed using MEME-Chip 23 . Motifs with the lowest e-value (most significant) were considered. MEG3 peaks were assigned to genes with the help of GREAT tool using criteria of proximal distance 5 kb upstream, 2 kb downstream of transcription start sites and up to 500 kb distal to gene promoters 24 .
Chromatin Immuno precipitation (ChIP)
H3K4me1 ChIP in BT-549 cells was performed with 3 μg of anti-H3K4me1 antibody (Santa Cruz) using protocol followed in Robertson et al. 25 . 100-300 ng of immunoprufied DNA from H3K4me1 ChIP was purified and sequenced on Illumina platform as reported in Robertson et al. 26 . Sequencing reads were analyzed and the enriched regions were defined by following the criteria from Robertson et al. 25 . Bedtools were used to calculate the closest distance between 
Visualization of the pathways using Cytoscape
The functional networks of the 300 genes, which were deregulated after MEG3 knockdown and were associated with at least one of the MEG3 peaks, were constructed with the help of Cluepedia 29 on Cytoscape 30 .
Analysis of MEG3 expression in breast cancer subtypes
Expression levels of MEG3 and target genes were assessed in a batch-corrected compendium of seventeen Affymetrix U133A/plus 2 primary breast tumors and three cell line gene expression datasets 31 . Briefly, Raw .cel files from seventeen Affymetrix U133A/plus 2 primary breast tumour and three cell line gene expression datasets were downloaded from NCBI GEO (GSE12276, GSE21653, GSE3744, GSE5460, GSE2109, GSE1561, GSE17907, GSE2990, GSE7390, GSE11121, GSE16716, GSE2034, GSE1456, GSE6532, GSE3494), or caBIG (geral-00143) repositories, summarized with Ensembl alternative CDF 32 and normalized with RMA 33 , before integrating using ComBat 34 to remove dataset-specific bias 35 . The intrinsic molecular subtypes were assigned based on the highest correlation to the Sorlie et al. 36 centroids for each subtype. To compare gene expression of MEG3 in normal breast tissue and invasive ductal carcinoma the dataset GSE10780 was downloaded from NCBI GEO 37 and pre-processed as above using Ensembl aCDF and RMA normalization. 
Nuclear and cytoplasmic RNA fractionation

Cell invasion assay
Invasion assay was performed using the biocoat invasion chamber (BD bioscience, 354480) following manufacturer's instructions. In brief, cells were seeded in 50,000-60,000 cells/ml density on the upper chamber in DMEM medium supplemented with 1% serum. DMEM medium containing 10 % serum was added to the lower chamber. The migrated cells were fixed and stained with SNABB-DIFF Kit (Labex AB, Sweden) and counted under light microscope.
Predicting Triplex Forming Oligo (TFO) and Triple-helix Target Site (TrTS)
Triplexator is a tool used in our analysis to predict the Triplex Forming Oligos (TFO's) and
Triplex Target Sites (TrTS) 38 . The TFO's in MEG3 transcript were considered using the default criteria by allowing 15 % error rate (number of mismatches) and less than 7 bp repeat length. To find TrTS over the MEG3 peaks summit (±200 bp from centre of the peak, total 400bp) we have used default criteria set by Triplexator that is up to 50 % of Guanine content with an error rate of less than 10 % (number of mismatches). As a control, we have used the flanking sequences of the MEG3 peak summit (200 bp up and 200 bp down-stream of the peak summit, total 400bp). 
Electrophoretic mobility shift assay
Triplex capture assay
For in vitro and in vivo Triplex capture assay, we have followed a protocol by Besch et al. 39 .
Nuclei from BT-549 cells were prepared by resuspending the cells in 1X nuclei isolation RNAs were in vitro transcribed with T7 RNA polymerase (Promega) using biotin RNA labeling Mix (Roche) and RNA quality was assessed in 0.8% agarose gel. 36 hours post RNA transfection, formaldehyde (1%) crosslinking was performed followed by nuclei isolation, nuclei lysis, chromatin fragmentation by sonication, streptavidin-magnetic bead pulldown and DNA isolation and purification following the same protocol described above.
CD spectroscopy
CD-spectra were recorded on a Jasco J-810 spectropolarimeter. Each spectrum is the average Supplementary Fig. 13 ).
Chromatin conformation capture (3C)
3C was performed according to the published protocol 40 . In brief, 2% formaldehyde fixed chromatin from Ctrlsh or MEG3sh BT-549 cells was digested with EcoRI. After ligation and DNA purification, we analyzed the 3C interactions between the TGFBR1 associated distal MEG3 peak and the TGFBR1 promoter in Ctrlsh or MEG3sh BT-549 cells using the primers provided in Supplementary Data 10. In order to measure the 3C interactions accurately, the difference in efficiency between the primers was normalized with a control BAC clone covering the whole TGFBR1 locus. The BAC clone was digested with EcoRI followed by ligation to generate all possible random combinations of ligation products. This ligated DNA was then used to check the efficiencies of the different primer pairs. 3C-qPCR data was normalized with the control 3C primers to eliminate the minor difference in cross-linking between the cell lines and also with the GAPDH primers for input amount (loading control). 
Luciferase Assay
